Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis: Impact of FLT3 on OS Post-HCT for AML
Author(s) -
Abhinav Deol,
Salyka Sengsayadeth,
Kwang Woo Ahn,
Hailin Wang,
Mahmoud Aljurf,
Joseph H. Antin,
Minoo Battiwalla,
Martin Bornhäuser,
JeanYves Cahn,
Bruce M. Camitta,
YiBin Chen,
Corey Cutler,
Robert Peter Gale,
Siddhartha Ganguly,
Mehdi Hamadani,
Yoshihiro Inamoto,
Madan Jagasia,
Rammurti T. Kamble,
John Koreth,
Hillard M. Lazarus,
Jane L. Liesveld,
Mark R. Litzow,
David I. Marks,
Taiga Nishihori,
Richard F. Olsson,
Ran Reshef,
Jacob M. Rowe,
Ayman Saad,
Mitchell Sabloff,
Harry C. Schouten,
Thomas C. Shea,
Robert J. Soiffer,
Geoffrey L. Uy,
Edmond K. Waller,
Peter H. Wiernik,
Baldeep Wirk,
Ann E. Woolfrey,
Donald Bunjes,
Steven M. Devine,
Marcos de Lima,
Brenda M. Sandmaier,
Dan Weisdorf,
H. Jean Khoury,
Wael Saber
Publication year - 2016
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/hk4z-at28
Subject(s) - myeloid leukemia , hematopoietic stem cell transplantation , hematopoietic cell , bone transplantation , medicine , haematopoiesis , oncology , stem cell , acute leukemia , transplantation , leukemia , overall survival , cancer research , biology , genetics , surgery
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom